EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) shot up 2.8% during trading on Tuesday . The stock traded as high as $2.65 and last traded at $2.59. 27,145 shares traded hands during trading, a decline of 71% from the average session volume of 94,668 shares. The stock had previously closed at $2.52.
EUDA Health Stock Performance
The firm's 50 day simple moving average is $3.25 and its 200 day simple moving average is $3.62.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in EUDA Health stock. XTX Topco Ltd bought a new stake in shares of EUDA Health Holdings Limited (NASDAQ:EUDA - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 16,463 shares of the company's stock, valued at approximately $75,000. XTX Topco Ltd owned 0.07% of EUDA Health at the end of the most recent quarter. Institutional investors own 4.35% of the company's stock.
EUDA Health Company Profile
(
Get Free Report)
EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.
Featured Stories
Before you consider EUDA Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.
While EUDA Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.